Xxera/openscience/retractions

Record #17794

Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase

Guray Saydam, Ibrahim C Haznedaroglu, Leylagul Kaynar, Akif S Yavuz, Ridvan Ali, Birol Guvenc, Olga M Akay, Zafer Baslar, Ugur Ozbek, Mehmet Sonmez, Demet Aydin, Mustafa Pehlivan, Bulent Undar, Simten Dagdas, Orhan Ayyildiz, Diyar Z Akkaynak, Gulnur Akin, Osman Ilhan

Journal

Publisher

Taylor and Francis

Original paper date

Feb 27, 2018

Original DOI

10.1080/10245332.2018.1444919

Country

🇹🇷 Turkey

Institution

Department of Internal Medicine , Ege University Medical Faculty Hospital , Izmir , Turkey · Department of Internal Medicine , Hacettepe University Medical Faculty Hospital , Ankara , Turkey · Hematology Division , Erciyes University Medical Faculty Hospital , Kayseri , Turkey · Department of Internal Medicine , Istanbul University Istanbul Medical Faculty , Istanbul , Turkey · Department of Internal Medicine , Uludag University Medical Faculty , Bursa , Turkey · Department of Internal Medicine , Cukurova University Medical Faculty Hospital , Adana , Turkey · Department of Internal Medicine , Eskisehir Osmangazi University Medical Faculty Hospital , Eskisehir , Turkey · Cerrahpasa Medical Faculty , Istanbul University , Istanbul , Turkey · Institute of Experimental Medicine (DETAE), Istanbul University , Istanbul , Turkey · Department of Internal Medicine , Karadeniz Technical University Medical Faculty , Trabzon , Turkey · Hematology Department , Okmeydani Training and Research Hospital , Istanbul , Turkey · Department of Internal Medicine , Gaziantep University Medical Faculty , Gaziantep , Turkey · Department of Internal Medicine , Dokuz Eylul University Medical Faculty , Izmir , Turkey · Department of Internal Medicine , Ankara Numune Training and Research Hospital , Ankara , Turkey · Department of Internal Medicine , Dicle University Medical Faculty Hospital , Diyarbakir , Turkey · Novartis Pharmaceuticals Corporation , Istanbul , Turkey. · Ankara University School of Medicine , Ankara , Turkey

Open access

No

Article type

Broad categories

(HSC) Medicine - Oncology (HSC) Medicine - Pharmacology (HSC) Medicine - Rehabilitation/Therapy

Citation lifecycle

How this paper is being cited

Pre-retraction

1

Same day

0

Post-retraction

10

% post-retraction

90.9%

~13.5 citations/yr before retraction · ~1.2 citations/yr after

— citing papers

Who is still citing this work

Loading…